Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: A retrospective study

Schizophrenia Research

Volumn 52, Issue 1-2, 2001, Pages 29-36

  Altamura, A C ^a   Bassetti, R ^a   Sassella, F ^a   Salvadori, D ^a   Mundo, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Clinical predictors; Duration of untreated psychosis; First episode; Outcome; Schizophrenia

Indexed keywords

APATHY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; NEGATIVE SYNDROME; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RECOGNITION; RECORDING; REGRESSION ANALYSIS; RELAPSE; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0035476954     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00187-0     Document Type: Article

References (59)

1. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia
2. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance
3. Novel antipsychotics and the problem of clinical stabilization in schizophrenia: Are they "stabilizer" rather than typical compounds?
4. Are atypical antipsychotics less depressogenic than typical compounds?
5. Negative symptoms in schizophrenia
6. The family history method using diagnostic criteria: Reliability and validity
7. Gender and the course of schizophrenia: Differences in treated outcomes
8. Premorbid adjustment as predictor of outcome in schizophrenia: Results of a prospective study
9. Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
10. High exposure to neuroleptics in bipolar patients: A retrospective review
11. The prediction of outcome in schizophrenia, IV: Eleven-year follow-up of the Washington IPSS cohort
12. Deficit and nondeficit forms of schizophrenia: The concept
13. Learning from outcome studies. Towards a comprehensive biological psychosocial understanding of schizophrenia
14. Evaluation of treatment-resistant schizophrenia
15. Is there an association between duration of untreated psychosis and 24-month clinical outcome in first-admission series?
16. Molecular pathology of schizophrenia: More than one disease process?
17. A randomized controlled trial of prophylactic neuroleptic treatment
18. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders
19. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
20. Pharmacologic treatment of first-episode schizophrenia: Early intervention is the key to the outcome
21. Remission and relapse in schizophrenia: The Madras Longitudinal Study
22. Early detection and intervention for initial episodes of schizophrenia
23. Qualitative MRI findings in patients with schizophrenia: A controlled study
24. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up
25. Is schizophrenia a disorder of all ages? A comparison of first episode and early course across the life-cycle
26. Two-year outcome in first-episode schizophrenia: Predictive value of symptoms for quality of life
27. Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia
28. Clozapine for the treatment-resistant schizophrenic
29. Deterioration in premorbid functioning in schizophrenia: A developmental model of negative symptoms in drug-free patients
30. Expressed emotion and relapse in young schizophrenia outpatients
31. First-episode schizophrenia with long duration of untreated psychosis. Pathways to care
32. Time course and biological correlates of treatment response in first-episode schizophrenia
33. Factors influencing treatment response and outcome of first episode schizophrenia: Implications for understanding the pathophysiology of schizophrenia
34. Clinical and biological markers for outcome in schizophrenia. A review of a longitudinal follow-up study in Uppsala. Schizophrenia Research Project
35. Duration of psychosis and outcome in first episode schizophrenia
36. Predictors of shorter-, medium-, and longer-term outcome in schizophrenia
37. A selective review of recent North American long-term follow-up studies of schizophrenia
38. Classical subtypes for schizophrenia: Literature review for D.S.M. IV
39. The positive-negative distinction in schizophrenia: Review of natural history validators
40. Northwick Park Study of first episodes of schizophrenia. III: Short-term outcome in trial entrants and trial eligible patients
41. Cognitive disfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics
42. Predictors of outcome in schizophrenia
43. Psychotic relapse and maintenance therapy in paranoid schizophrenia: A 15-year follow-up
44. Health care costs of therapy refractory schizophrenic patients treated with clozapine: A study in a community psychiatric service in Italy
45. Pharmacotherapy of first-episode schizophrenia
46. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
47. Outcome of schizophrenia in relation to brain abnormalities
48. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients
49. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
50. Olanzapine versus haloperidol in the treatment of first episode psychosis
51. Sociodemographic and clinical variables as predictors of the diagnostic characteristics of first episode of schizophrenia
52. Anchoring the BPRS: An aid to improved reliability
53. Neurocognitive deficits and neurological signs in schizophrenia
54. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia
55. First-episode schizophrenia: Early intervention and discontinuation in the context of course and treatment
56. Clinical predictors of acute response with olanzapine in psychotic mood disorders
57. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey